Evaluation of Endothelial Dysfunction Using the Flow Mediated Dilation Test in a Population of Chronic Renal Failure Patients at Different Stages, and Evaluation of the Role of Antiphospholipid Antibodies
A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 200 participants.
Also called NCT06347029
- Study
- In this atlas
Overview
- Design
- Interventional study; non-randomized; no masking; primary purpose basic science
- Phase
- Not applicable
- Enrolled
- 200 participants
- Sponsor
- Brugmann University Hospital
- Registry
-
NCT06347029
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Belgium
- Registry status
- Unknown status
Technical summary
Registry record NCT06347029. Non-randomized; no masking; primary purpose basic science. Start 2023-10-17 (actual); primary completion 2024-12-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Evaluation of Endothelial Dysfunction Using the "Flow Mediated Dilation" Test in a Population of Chronic Renal Failure Patients at Different Stages, and Evaluation of the Role of Antiphospholipid Antibodies
- Condition
- Chronic Renal Failure
- Intervention (Procedure)
- Urine sampling
- Intervention (Procedure)
- Blood sampling
- Intervention (Device)
- Flow mediated dilatation test
- Lead sponsor
- Brugmann University Hospital
Record details
- Record id
cardio:ct-nct06347029- Content hash
1659c14d3aec41a7ce2097afc9fe58f70ee0f1559b5237b0444495f30823e53b